Loading
Latest filing published 05 Jan 2026 for Gossamer Bio, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Caryn Peterson (senior executive) discloses dealings in Gossamer Bio, Inc. to SEC (Form 4). We count 7 filings; the first trade dates from 25 October 2021 and the latest from 2 January 2026.
On the market, this insider has only sold: 5 sales, €143k in total. Other entries cover 2 share grants.
Most recently, on 5 January 2026, the filings show a share grant in Gossamer Bio, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations